# Haemonetics (HAE) — Overview

HAE · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/hae

## Price

Last close $121.29 on Oct 15, 2026. 52-week range $48.58 – $122.06.

## Company profile

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $1.4B |
| Revenue (quarter) | $339.4M |
| Revenue growth (year over year) | 5.60% |
| Gross profit (trailing twelve months) | $798.1M |
| Gross margin | 59.03% |
| Net income (trailing twelve months) | $96.3M |
| Net income (quarter) | $33.0M |
| Net income growth (year over year) | -3.00% |
| Net margin | 7.12% |
| Return on equity | 11.20% |
| EPS (trailing twelve months) | $2.08 |
| Book value per share | $18.41 |
| P/E (trailing twelve months) | 57.3 |
| Price to book | 6.6 |
| Debt to assets | 64.61% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is Haemonetics (HAE) profitable?

Yes. Haemonetics earned $96.3M in net income over the trailing twelve months, a net margin of 7.12%.

### How much revenue does Haemonetics (HAE) make?

Haemonetics generated $1.4B in revenue over the trailing twelve months, up 5.60% year over year.

### What is HAE's P/E ratio?

Haemonetics trades at 57.3 times trailing twelve-month earnings, on an EPS of $2.08.

### How do I buy stock in Haemonetics (HAE)?

HAE trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

## Similar Stocks

- [PODD](https://www.lighthorse.io/tickers/podd) — Insulet Corporation - Common Stock
- [DXCM](https://www.lighthorse.io/tickers/dxcm) — DexCom, Inc. - Common Stock
- [QTRX](https://www.lighthorse.io/tickers/qtrx) — Quanterix Corporation - Common Stock
- [SIBN](https://www.lighthorse.io/tickers/sibn) — SI-BONE, Inc. - Common Stock
- [PEN](https://www.lighthorse.io/tickers/pen) — Penumbra, Inc. Common Stock
- [ZBH](https://www.lighthorse.io/tickers/zbh) — Zimmer Biomet Holdings, Inc. Common Stock
- [HQY](https://www.lighthorse.io/tickers/hqy) — HealthEquity, Inc. - Common Stock
- [LNTH](https://www.lighthorse.io/tickers/lnth) — Lantheus Holdings, Inc. - Common Stock

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).